Expert Q&A
Expert Q&A
02/22/2022
Vivian Bykerk, BSc, MD, from Hospital for Special Surgery, answers our questions on new research about the impact of HLA-DRB1 risk alleles on the clinical efficacy of 2 biologic agents for the...
02/22/2022
asthma
asthma
02/14/2022
Vanessa Kronzer, MD, from the Mayo Clinic, answers our questions about her study that assessed the association between rheumatoid arthritis, asthma, passive smoke exposure, and more.
02/14/2022
Rheumatoid Arthritis
Rheumatoid Arthritis
01/28/2022
William G. Dixon, MRCP, MSc, PhD, answers our questions about remote monitoring of RA and how it may improve the collection of patient-generated health data to benefit the overall management of RA.
01/28/2022
Treatment
Treatment
03/10/2020
A new analysis of the ArthritisPower registry aimed to identify factors that patients believe influenced their physician’s treatment decisions. Lead authors W. Benjamin Nowell, PhD, and Kelly Gavigan, MPH,...
03/10/2020
Rheumatoid Arthritis
Rheumatoid Arthritis
11/27/2019
Jeffrey Ruth, PhD, from the University of Michigan Medical School, answers our questions about his research on the role of inhibitor of DNA binding 1 protein in rheumatoid arthritis.
11/27/2019
Rheumatoid Arthritis
Rheumatoid Arthritis
11/27/2019
Jeffrey Ruth, PhD, from the University of Michigan Medical School, answers our questions about his research on the role of inhibitor of DNA binding 1 protein in rheumatoid arthritis.
11/27/2019
Pulmonary disorders
Pulmonary disorders
09/06/2019
Bryant England, MD, answers our questions about his research into the role of anti-malondialdehyde-acetaldehyde antibodies in RA–associated ILD.
09/06/2019
Treatment
Treatment
09/03/2019
Michael Ward, MD, PhD, from the National Institutes of Health, answers our questions about his research that measured minimal clinically important improvement of the Routine Assessment of Patient Index Data...
09/03/2019
Rheumatoid Arthritis
Rheumatoid Arthritis
01/22/2017
While treat-to-target is now canonical, many clinicians are overlooking and dismissing certain assessments in managing rheumatoid arthritis.
01/22/2017
Rheumatoid Arthritis
Rheumatoid Arthritis
01/22/2017
While treat-to-target is now canonical, many clinicians are overlooking and dismissing certain assessments in managing rheumatoid arthritis.
01/22/2017